Building a quality at reasonable price stocks watchlist in 2026 means owning great businesses without overpaying. This guide covers the qarp watchlist 2026 framework and 10 names screened from the S&P 500 this month.
The goal is simple. Pay a fair multiple for companies that compound capital and generate real cash.
Defining Quality: ROIC, FCF Conversion, Net Cash
Return on invested capital, or ROIC, measures how efficiently a company turns debt and equity into operating profit. A sustained ROIC above 15% usually signals a durable competitive advantage.
Free cash flow conversion tells you whether earnings turn into cash. We want FCF conversion above 80% of net income across a full cycle.
Net cash, or at worst modest debt, is the third pillar. According to Sure Dividend, the highest ROIC names in the S&P 500 tend to pair capital efficiency with conservative balance sheets, which insulates earnings during rate cycles.
A quick example. A stock with 25% ROIC, 95% FCF conversion, and net cash is a quality business. Now we just need to avoid paying a stupid price for it.
Reasonable Price: Multiples Relative to History and Peers
Reasonable does not mean cheap. A 10 P/E stock can be a value trap if earnings are melting.
Compare the forward P/E to the company's 5 or 10-year median. A multiple 15 to 25% below the long-run median suggests the market is asking less than usual for the same cash flows.
Then cross-check against sector peers. If a name trades at a discount while outgrowing peers on revenue and margin, that is mispricing, not a broken business.
Finally, sanity-check with EV/EBITDA. It strips out capital structure differences and flags companies where P/E looks low only because of leverage.
Ready to act on this framework? Open the watchlist inside Gotrade app and add the 10 names below in two taps.
Filtering With a Free Screener Step by Step
You do not need a paid terminal. Finviz and Stock Analysis both run the screen for free.
Step one, limit to US large-cap, market cap above US$10B. This removes micro-cap noise.
Step two, filter for ROIC above 15%. This alone cuts the S&P 500 to roughly 80 names.
Step three, add Net Debt to EBITDA below 1x. This forces balance sheet discipline and brings the list to around 40 companies.
Step four, require Forward P/E at least 10% below the 5-year average. You should exit with around 20 candidates.
From there, judgment takes over. Read the last two 10-Ks, confirm FCF conversion has held above 80%, and drop any name where quality is deteriorating.
April 2026 Sample Watchlist: 10 Names That Pass
Applying the screen on April 24, 2026 produced the following list. Four of the ten also appear on recent Morningstar wide moat coverage, which adds a second layer of validation.
| Ticker | Company | Quality Rationale | Why Price Is Reasonable |
|---|---|---|---|
| GOOGL | Alphabet | ROIC ~28%, FCF conversion >90%, net cash of ~US$95B | Forward P/E ~18x vs 5-year average near 23x |
| META | Meta Platforms | ROIC >30%, operating margins ~42%, net cash position | Forward P/E ~20x, below post-2022 recovery peak multiple |
| MA | Mastercard | Capital-light model, ROE >170%, FCF margin ~40% | Forward P/E ~27x vs 5-year average of ~33x |
| CSCO | Cisco Systems | ROIC ~22%, >80% recurring revenue mix, strong cash flow | Forward P/E ~14x, discount to both history and software peers |
| GILD | Gilead Sciences | Zero net debt, FCF margin >40%, durable HIV franchise | Forward P/E ~11x, below large-cap biotech median |
| UNH | UnitedHealth Group | ROIC ~15%, reinvestment runway in Optum, wide moat | Forward P/E ~14x, well under the 5-year average near 20x |
| CVX | Chevron | Integrated cash generation, strong FCF even at US$70 oil | Forward P/E ~12x with ~4% dividend yield |
| ABBV | AbbVie | FCF conversion ~95%, post-Humira growth now visible | Forward P/E ~14x, discount to pharma peer set |
| TXN | Texas Instruments | ROIC ~25%, analog moat, disciplined capital returns | Forward P/E in the mid-20s, below 5-year peak multiples |
| LOW | Lowe's | ROIC ~30%, buyback-heavy capital return, resilient margins | Forward P/E ~16x, discount to Home Depot and 5-year median |
We exited with 10 names because that is the sweet spot for a watchlist you will monitor. According to the Quality Stocks newsletter, the 2026 correction handed investors a chance to upgrade portfolio quality at fair prices.
This is a research list, not a buy recommendation. Multiples can compress further and position sizing matters more than the starting universe.
Conclusion
A qarp watchlist 2026 is not magic. It is a repeatable process: define quality, demand a reasonable multiple, run a free screen, and narrow with judgment.
Used monthly, the method builds a living pipeline. You stop chasing headlines and start waiting for great businesses to reach fair prices.
Take the next step. Add these 10 names to your Gotrade watchlist, then start a fractional position from just US$1, including Alphabet (GOOGL), Meta Platforms (META), Mastercard (MA), Cisco Systems (CSCO), and Gilead Sciences (GILD). For process depth, see how to build a stock watchlist and our primer on growth investing.
FAQ
What does QARP mean in investing?
QARP stands for quality at a reasonable price, a strategy that blends high returns on capital with valuation discipline.
Is ROIC better than ROE for screening?
ROIC is typically more honest because it accounts for both debt and equity funding, so leverage cannot inflate the number.
How many stocks should a watchlist have?
Ten to twenty names is a practical range that balances coverage with the depth of research you can realistically maintain.
Can I buy these stocks fractionally on Gotrade?
Yes, you can start a fractional position in any of the 10 names from as little as US$1 directly inside the Gotrade app.
